The identification of a metabolic pathway could lead to answers and new treatments for those experiencing brain fog because of long COVID.
We know from other viruses that viral fragments can remain in different tissues for months or even years. This could be the case for long COVID.
Mainstream medicine hasn’t yet found enough evidence-based treatments for long COVID. No wonder sufferers are turning to unproven therapies.
Research into the social dimensions of long Covid offers invaluable insights for its prevention, treatment and care.
What do disadvantaged communities need to weather long COVID? Ask them.
It’s estimated one in 10 people infected with SARS-CoV-2 will have lingering symptoms, but most people will improve over time.
A team from UNSW's Kirby Institute and St Vincent’s Hospital Sydney have uncovered an immune profile for long COVID, potentially paving the way for tailored treatment for those with ongoing symptoms.
Sufferers collected evidence of their persistent symptoms, and advocated for themselves and for further research. Even the term ‘long COVID’ stems from this activism.
One study suggests getting vaccinated halves the risk of developing long COVID.
A UNSW psychology researcher is behind neurocognitive testing recommendations that will help assess long COVID patients.